AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Travere Therapeutics to Present at Multiple Investor Conferences
ByAinvest
Tuesday, Aug 5, 2025 11:06 pm ET1min read
Travere Therapeutics Inc. (TVTX) will participate in several upcoming investor conferences, including the Canaccord Genuity 45th Annual Growth Conference and the Cantor Global Healthcare Conference 2025. The company will provide live webcasts of its presentations, available on its Investor page. The participation highlights Travere's commitment to communicating its mission and progress in rare disease therapies.
Travere Therapeutics, Inc. (TVTX) has announced its participation in several upcoming investor conferences, including the Canaccord Genuity 45th Annual Growth Conference and the Cantor Global Healthcare Conference 2025. The company will present at these events, providing investors and industry professionals with insights into its mission and progress in rare disease therapies. The presentations will be available live via webcast on Travere's Investor page at ir.travere.com/events-and-presentations, with replays accessible for up to 30 days following each event.The Canaccord Genuity 45th Annual Growth Conference will take place on Wednesday, August 13, 2025, at 8:00 a.m. ET. The Citi's 2025 Biopharma Back to School Conference is scheduled for Tuesday, September 2, 2025, at 3:15 p.m. ET. Travere will also present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 1:30 p.m. ET, and the Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025, at 2:45 p.m. ET.
Travere Therapeutics is committed to developing life-changing therapies for patients with rare diseases. The company's global team works closely with the rare disease community to identify, develop, and deliver innovative treatments. By participating in these investor conferences, Travere aims to communicate its mission and progress to a broader audience, fostering a deeper understanding of its efforts in the rare disease space.
References:
[1] https://ir.travere.com/press-releases/news-details/2025/Travere-Therapeutics-to-Participate-at-Upcoming-Investor-Conferences-e8c0b6adb/default.aspx
[2] https://www.morningstar.com/news/business-wire/20250805058669/travere-therapeutics-to-participate-at-upcoming-investor-conferences
[3] https://www.marketscreener.com/news/travere-therapeutics-to-participate-at-upcoming-investor-conferences-ce7c5ed8df81f121
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet